
Location: Boston, Massachusetts
Date:
Event description: Details: Description: Novotech is proud to participate in BIO International Convention 2025, the world’s largest and most influential biotechnology event. Bringing together over 20,000 industry leaders under the theme “The World Can’t Wait,” BIO provides a powerful platform to engage with decision-makers across the global biotech ecosystem. Alongside BIO, Novotech will also attend RESI Boston, a key partnering forum that connects early-stage biotechs with investors and strategic partners. Our presence across both events reflects Novotech’s commitment to enabling global biotech innovation from seed to late-stage development. Meet our attending senior leaders: John Moller, Chief Executive Officer, Barry Murphy, Chief Commercial Officer, Dr. Judith Ng-Cashin, Chief Medical Officer, Scott Schliebner, VP - Drug Development Consulting, and Dr. Yooni Kim, Managing Director - Asia-Pacific, Plus key representatives from our clinical, regulatory, and business development teams, including Steve Roan, Matt Nicola, Derrick Ferrar, Angela Wang, Lainie Mulvanny, Lillian Kim, Jinah Lee, Pete Robinson, Tom Hickey, and Donna Fraser. Novotech’s biotech-focused model supports small to midsized sponsors with integrated CRO services across Asia Pacific, North America, and Europe. Whether you’re launching first-in-human trials or expanding global operations, we offer tailored strategies to accelerate clinical development with quality and speed. Request a meeting via BIO Partnering™, RESI or the form on this page to explore how we can support your next breakthrough.
Schedule a meeting with our attendees
Meet Our Team
John Moller
Barry Murphy
Dr. Judith Ng-Cashin
Scott Schliebner
Dr. Yooni Kim
Angela Wang
Matthew Nicola
Lilian Kim
Tom Hickey
Pete Robinson
Steven Roan
Lainie Mulvanny
Jinah Lee
Derrick Ferrar
Plus experts from our global commercial teams.